Stock Track | Inspire Medical Systems Plunges 7.65% After-Hours Despite Strong Q4 Results as 2026 Outlook Disappoints

Stock Track

Feb 12

Inspire Medical Systems' stock plunged 7.65% in after-hours trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.

The medical technology company reported strong quarterly performance with Q4 revenue of $269.1 million, beating analyst estimates of $265.7 million and representing 12% year-over-year growth. Net income per diluted share surged 182% to $4.66 for the quarter, while adjusted EPS came in at $1.65.

Despite these positive results, investors reacted negatively to the company's revised 2026 outlook. Inspire Medical Systems now expects 2026 revenue between $950 million and $1 billion, representing growth of just 4% to 10%. The company also provided adjusted EPS guidance of $1.85 to $2.35 for 2026, with an adjusted operating margin projected between 6% and 8%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1136021795"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136021795\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136021795?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 05:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136021795","market":"us","top_or_hot":-1,"title":"Stock Track | Inspire Medical Systems Plunges 7.65% After-Hours Despite Strong Q4 Results as 2026 Outlook Disappoints","media":"Stock Track","content":"<p>Inspire Medical Systems' stock plunged 7.65% in after-hours trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.</p><p>The medical technology company reported strong quarterly performance with Q4 revenue of $269.1 million, beating analyst estimates of $265.7 million and representing 12% year-over-year growth. Net income per diluted share surged 182% to $4.66 for the quarter, while adjusted EPS came in at $1.65.</p><p>Despite these positive results, investors reacted negatively to the company's revised 2026 outlook. Inspire Medical Systems now expects 2026 revenue between $950 million and $1 billion, representing growth of just 4% to 10%. The company also provided adjusted EPS guidance of $1.85 to $2.35 for 2026, with an adjusted operating margin projected between 6% and 8%.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Inspire Medical Systems Plunges 7.65% After-Hours Despite Strong Q4 Results as 2026 Outlook Disappoints</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Inspire Medical Systems Plunges 7.65% After-Hours Despite Strong Q4 Results as 2026 Outlook Disappoints\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-12 05:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Inspire Medical Systems' stock plunged 7.65% in after-hours trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.</p><p>The medical technology company reported strong quarterly performance with Q4 revenue of $269.1 million, beating analyst estimates of $265.7 million and representing 12% year-over-year growth. Net income per diluted share surged 182% to $4.66 for the quarter, while adjusted EPS came in at $1.65.</p><p>Despite these positive results, investors reacted negatively to the company's revised 2026 outlook. Inspire Medical Systems now expects 2026 revenue between $950 million and $1 billion, representing growth of just 4% to 10%. The company also provided adjusted EPS guidance of $1.85 to $2.35 for 2026, with an adjusted operating margin projected between 6% and 8%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INSP","symbol_name":"Inspire Medical Systems","start_time":0,"source_url":"","article_id":"1136021795","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136021795","pubTimestamp":1770846781,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Inspire Medical Systems' stock plunged 7.65% in after-hours trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.The medical technology company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INSP":"Inspire Medical Systems"},"translate_title":"个股追踪|Inspire Medical Systems盘后暴跌7.65%，尽管第四季度业绩强劲，2026年前景令人失望","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INSP":1},"content_text":"Inspire Medical Systems' stock plunged 7.65% in after-hours trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.The medical technology company reported strong quarterly performance with Q4 revenue of $269.1 million, beating analyst estimates of $265.7 million and representing 12% year-over-year growth. Net income per diluted share surged 182% to $4.66 for the quarter, while adjusted EPS came in at $1.65.Despite these positive results, investors reacted negatively to the company's revised 2026 outlook. Inspire Medical Systems now expects 2026 revenue between $950 million and $1 billion, representing growth of just 4% to 10%. The company also provided adjusted EPS guidance of $1.85 to $2.35 for 2026, with an adjusted operating margin projected between 6% and 8%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}